Brief: Aclaris Therapeutics Inc -Files Prospectus For Offer, Resale By Selling Stockholders Of Up To 35.6 Million Shares Of Common Stock
19/12/2024 21:35
Aclaris Therapeutics Inc ACRS.O :
* ACLARIS THERAPEUTICS INC -FILES PROSPECTUS FOR OFFER,
RESALE BY
SELLING STOCKHOLDERS OF UP TO 35.6 MILLION SHARES OF COMMON
STOCK
Source text: ID:n0001104659-24-130186
Further company coverage: ACRS.O
Recent news on Aclaris Therapeutics
See all newsAclaris Therapeutics Q1 net loss widens on higher R&D spending
Brief: Aclaris Therapeutics Q1 EPS USD -0.15 Vs. IBES Estimate USD -0.16
Brief: Aclaris Therapeutics Says Positive Full Top Line Results From Phase 1A Clinical Trial Of ATI-055
Brief: Aclaris Therapeutics Completes Enrollment In Phase 2 Trial Of Bosakitug (Ati-045) In Atopic Dermatitis
Aclaris Q4 loss narrows, but misses analysts' expectations